(NYSE: BAX) Baxter International's forecast annual revenue growth rate of 3.14% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.85%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.27%.
Baxter International's revenue in 2024 is $14,813,000,000.On average, 7 Wall Street analysts forecast BAX's revenue for 2024 to be $7,670,373,894,060, with the lowest BAX revenue forecast at $7,658,037,749,960, and the highest BAX revenue forecast at $7,683,677,449,427. On average, 7 Wall Street analysts forecast BAX's revenue for 2025 to be $7,961,376,281,593, with the lowest BAX revenue forecast at $7,935,819,357,999, and the highest BAX revenue forecast at $7,991,715,923,990.
In 2026, BAX is forecast to generate $8,252,743,289,227 in revenue, with the lowest revenue forecast at $8,212,077,483,727 and the highest revenue forecast at $8,327,425,407,767.